journal
https://read.qxmd.com/read/37594000/novel-and-highly-reliable-leak-check-tests-for-drop-and-external-pressure-type-cell-free-and-concentrated-ascites-reinfusion-therapy
#21
JOURNAL ARTICLE
Yasuko Kobayashi, Nana Ozawa, Tamami Yoshida, Takashi Minowa, Yuki Michinaga, Keita Inui, Koji Hashimoto, Yuji Kamijo
INTRODUCTION: For safe management of cell-free and concentrated ascites reinfusion therapy (CART), a highly reliable leak test for detecting ascites filter damage is essential. However, such a test has not been established for drop-type CART. METHODS: We devised two novel leak tests for drop- and external pressure-type CART, manual or pump pressurization methods, using high-pressure loading and pressure monitoring, and investigated their reliability. RESULTS: Both methods could easily load and maintain sufficiently high pressure (>400 Torr) on the hollow fibers for 2 min...
August 18, 2023: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37593995/updated-evidence-of-beneficial-effect-of-ldl-apheresis-for-refractory-nephrotic-syndrome-due-to-a-variety-of-causative-diseases-for-nationwide-and-global-approval
#22
REVIEW
Eri Muso, Hiroko Kakita, Hiroyuki Suzuki, Tatsuo Tsukamoto
Low-density lipoprotein apheresis (LDL-A) therapy has shown reasonable efficacy in treating nephrotic syndrome (NS) refractory to initial drug therapy and has been covered by National Health Insurance for the indication of drug-resistant focal segmental glomerulosclerosis (FSGS) since 1992 in Japan and has contributed to liberating substantial number of patients of this disease from entering into end-stage renal disease by easier practical application in actual clinical settings. Subsequently, various beneficial evidence of this treatment has accumulated on those other than FSGS, however, due to the limitation of covered disease insurance only for FSGS, patients with diseases other than FSGS are unlikely to benefit from this treatment in practice...
August 18, 2023: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37592760/the-43rd-annual-meeting-of-the-japanese-society-for-apheresis
#23
EDITORIAL
Takashi Wada
No abstract text is available yet for this article.
August 17, 2023: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37589198/evaluation-of-the-treatment-volume-and-removal-rate-of-rheocarna-a-novel-adsorption-type-blood-purification-device-for-patients-with-chronic-limb-threatening-ischemia
#24
JOURNAL ARTICLE
Atsushi Ohkubo, Takatoshi Sakurasawa, Yuki Hoshikawa, Mana Usui, Misaki Hoshi, Takuto Shiga, Masaya Deushi, Shigeto Komori, Ayako Itagaki, Hiroko Yamamoto, Hiroshi Seshima, Naoki Kurashima, Soichiro Iimori, Shotaro Naito
INTRODUCTION: Chronic limb-threatening ischemia (CLTI) is a clinical syndrome defined by peripheral arterial disease (PAD) combined with rest pain, gangrene, or leg ulceration for longer than two weeks resulting in lower extremity amputation. In recent years, low-density lipoprotein apheresis (LDL-A) has been implemented for PAD treatment. However, it has not been possible to ensure insurance coverage for patients with lower LDL levels than 140 mg/dL under cholesterol-lowering drugs...
August 17, 2023: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37587685/current-status-of-low-density-lipoprotein-apheresis-treatment-for-patients-with-peripheral-artery-disease-and-chronic-kidney-disease-in-japanese-clinical-database
#25
JOURNAL ARTICLE
Yu Watanabe, Akihito Tanaka, Kazuhiro Furuhashi, Shoichi Maruyama
INTRODUCTION: Patients with peripheral arterial disease (PAD) have a poorer prognosis than those without PAD. PAD complications worsen the prognosis of patients with chronic kidney disease (CKD), especially those on maintenance dialysis. Although low-density lipoprotein apheresis (LDL-A) is expected to be effective in treating severe PAD, there are no large-scale reports on the prognosis of patients undergoing LDL-A. METHODS: We obtained a clinical database from April 2008 to August 2021 and selected 924 238 patients with CKD...
August 16, 2023: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37583361/a-nephrologist-dream-of-peritoneal-dialysis-catheter-with-zero-migration-a-multicenter-prospective-study
#26
JOURNAL ARTICLE
Abdullah K Al-Hwiesh, Ibrahiem Saeed Abdul-Rahman, Jose Carolino Divino-Filho, Mohamed A Nasreldin, Amani A Al-Hwiesh, Nadia Al-Audah, Hatem H Althubaini, Moaz Abdulgalil, Ghassan A Salah, Mohammad Z Al-Baggal, Bassam A Abu-Oun, Nehad Al-Audah, Habib S Al-Ramadan, Kaltham Alfalah, Zahra Almarri, Ayat A Al-Awal
INTRODUCTION: PD catheter tip migration is a common complication and a significant cause of catheter malfunction. In this perspective, we present our experience with a new catheter and a new technique that involves the use of a new triple cuff PD catheter and a low entry site in an attempt to prevent PD catheter migration. METHODS: A total of 503 incident PD patients have been studied in more than one PD center over a period of 5 years. RESULTS: During the 5-year follow up we recorded zero percent catheter migration...
August 16, 2023: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37583277/double-filtration-plasmapheresis-for-bullous-pemphigoid-outcomes-from-the-evaluation-of-eight-patients
#27
LETTER
Hisao Kawahira, Kazuyasu Fujii, Yuko Higashi, Yasutoshi Yamada, Akihiko Mitsuke, Hideki Enokida, Takuro Kanekura
No abstract text is available yet for this article.
August 15, 2023: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37503708/an-increase-in-fibrinogen-levels-despite-plasma-exchange-in-a-myasthenia-gravis-patient-a-case-report
#28
LETTER
Mohadese Golsorkhi, Sayna Norouzi, Amir Abdipour
No abstract text is available yet for this article.
July 28, 2023: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37493174/a-case-of-self-remitting-periaortitis-in-a-hemodialysis-patient-after-covid-19
#29
LETTER
Satoshi Matsui, Tomonaga Ameku, Shinji Ono
No abstract text is available yet for this article.
July 26, 2023: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37469222/diuretics-or-ultrafiltration-in-the-treatment-of-acute-decompensated-heart-failure-an-updated-systematic-review-and-meta-analysis
#30
JOURNAL ARTICLE
Vasileios Terpos, Stefanos Roumeliotis, Panagiotis I Georgianos, Eleni Papa, Dimitrios G Tsalikakis, Evangelos Papachristou, Vassilios Liakopoulos
INTRODUCTION: Hospitalization for decompensated heart failure is a major public health issue. METHODS: We performed a meta-analysis to summarize and analyze if there is a benefit in using ultrafiltration over diuretics in terms of reducing mortality or hospital readmissions, primarily and identified 10 randomized controlled trials (RCTs) including 941 patients. RESULTS: Compared to diuretics, treatment with ultrafiltration was associated with a significant reduction in heart failure hospitalizations (risk ratio [RR]: 0...
July 19, 2023: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37461148/the-effect-of-double-filtration-plasmapheresis-and-corticosteroids-on-patients-with-anti-dipeptidyl-peptidase-like-protein-6-encephalitis
#31
JOURNAL ARTICLE
Wenbin Wan, Yuanmei Pan, Ying Chen, Shuwei Bai, Xiaoying Yao, Yan Lin, Jun Wu, Liping Ni, Yufang Mei, Huiying Qiu, Yan Zhou, Yong Hao, Yangtai Guan
INTRODUCTION: Anti-dipeptidyl-peptidase-like protein 6 (DPPX) encephalitis is a rare condition with varied symptoms including gastrointestinal issues, weight loss, cognitive and mental dysfunction, and hyperexcitability of the central nervous system. METHODS: We studied five patients with anti-DPPX encephalitis who received immunotherapy, specifically DFPP, at our hospital. We analyzed their clinical symptoms, lab results, electrophysiological and imaging findings, and outcomes with immunotherapy...
July 17, 2023: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37439003/geriatric-depression-scale-predicts-mortality-in-elderly-patients-on-chronic-hemodialysis
#32
JOURNAL ARTICLE
Maurizio Bossola, Gilda Pepe, Emanuela Antocicco, Camilla Illuminati, Enrico Di Stasio
INTRODUCTION: The aim of this study was to determine if the Geriatric Depression Scale (GDS) was predictor of mortality in elderly patients on chronic hemodialysis (HD). METHODS: A total of 140 HD patients ≥65 years were studied. Symptoms of depression were assessed through GDS and cognitive function through the Mini Mental State Examination (MMSE). GDS scores 0-9 are considered normal (Group 1); scores of 10-20 (Group 2) and 21-30 (Group 3) indicate mild and severe depression...
July 12, 2023: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37429638/evaluation-of-the-changes-in-electrocardiographic-ventricular-repolarization-parameters-after-covid-19-recovery-in-hemodialysis-patients
#33
JOURNAL ARTICLE
Raziye Yazıcı, İbrahim Güney
INTRODUCTION: Coronavirus disease-2019 (COVID-19) has cardiac manifestations. Data about electrocardiogram (ECG) changes after COVID-19 recovery is limited in hemodialysis patients. We aimed to investigate the changes in ventricular repolarization parameters after COVID-19 recovery in hemodialysis patients. METHODS: Fifty-five hemodialysis patients who recovered from COVID-19 infection were included. QT interval, Tp-e interval, corrected QT (QTc), QTc dispersion, and Tp-e dispersion values were determined on the patients' ECGs, taken before COVID-19 and at least 1 month after recovery...
July 10, 2023: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37424269/effects-of-sodium-thiosulfate-on-serum-calcification-factors-in-patients-undergoing-maintenance-hemodialysis
#34
JOURNAL ARTICLE
Pan Liu, Xiang Xu, YuFu Wang, XiaoNa Long, XunJia Li, HongYing Peng
OBJECTIVE: To investigate the effect of sodium thiosulfate (STS) on serum calcification factors in patients undergoing maintenance hemodialysis. METHODS: Forty-four Patients were randomly divided into control group (n = 22) and observation group (n = 22) by envelope method (block 4 randomization). The control group received routine treatment while observation group was treated with STS on the basis of routine treatment. The biochemical indicators, including BUN, UA, SCr, Ca2+ , P3- , calcium-phosphorus product, PTH, hs-CRP, TG, TC, HDL, LDL, and serum calcification factor MGP, FA, FGF-23, and OPG levels were compared before and after treatment...
July 9, 2023: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37401120/post-dialysis-fatigue-and-peri-dialytic-serum-lactate-levels-in-patients-on-chronic-hemodialysis
#35
LETTER
Maurizio Bossola, Nunzia Ciferri, Enrico Di Stasio
No abstract text is available yet for this article.
July 3, 2023: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37395555/efficacy-of-molnupiravir-and-sotrovimab-in-japanese-dialysis-patients-with-covid-19-in-clinical-practice-during-the-omicron-ba-1-and-ba-2-pandemic
#36
JOURNAL ARTICLE
Kan Kikuchi, Masaomi Nangaku, Munekazu Ryuzaki, Tomoyuki Yamakawa, Yoshihiro Ota, Norio Hanafusa, Ken Sakai, Yoshihiko Kanno, Ryoichi Ando, Toshio Shinoda, Shu Wakino, Hidetomo Nakamoto, Yoshiaki Takemoto, Tadao Akizawa
INTRODUCTION: In the present study, the efficacy of sotrovimab and molnupiravir in dialysis patients with COVID-19 was investigated using a registry of COVID-19 in Japanese dialysis patients. METHODS: Dialysis patients with confirmed SARS-CoV-2 during the COVID-19 (Omicron BA.1 and BA.2) pandemic were analyzed. Patients were classified into four treatment groups: molnupiravir monotherapy (molnupiravir group), sotrovimab monotherapy (sotrovimab group), molnupiravir and sotrovimab combination therapy (combination group), and no antiviral therapy (control group)...
July 3, 2023: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37386825/determination-of-anxiety-depression-avoidance-and-obsessions-experienced-by-hemodialysis-patients-during-the-covid-19
#37
JOURNAL ARTICLE
Nazlı Koşunalp, Mehtap Kavurmaci
INTRODUCTION: The purpose of this study was to ascertain the levels of anxiety, despair, avoidance, and obsessions that hemodialysis patients dealt with during the pandemic. METHODS: The study was conducted with 139 hemodialysis patients. Research data "Coronavirus Anxiety Scale (CAS)," "Hospital Anxiety and Depression Scale (HAD)," "COVID-19 Avoidance Scale" (AA-COVID-19) and "Coronavirus Obsession Scale (OCS)." The data obtained from the research were analyzed using the SPSS 21 package program...
June 29, 2023: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37381103/body-surface-area-and-treatment-failure-in-peritoneal-dialysis-associated-peritonitis
#38
JOURNAL ARTICLE
Yuting Zhang, Peng He, Lijie He
INTRODUCTION: This study mainly discussed the relationship between body surface area (BSA) and treatment failure of peritoneal dialysis-associated peritonitis (PDAP). METHODS: The exposures were BSA grouped by the tertiles of BSA levels. The association between BSA and the risk of treatment failure in PDAP, defined as the temporary or permanent switch to hemodialysis and kidney transplantation, was evaluated in Cox proportional hazards models. RESULTS: A total of 483 episodes in 285 patients were recorded in our center...
June 28, 2023: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37381091/water-quality-and-adverse-health-effects-on-the-hemodialysis-patients-an-overview
#39
REVIEW
Raquel Raimundo, Laura Preciado, Rita Belchior, Cristina M M Almeida
Hemodialysis is considered a treatment of choice for patients with renal failure worldwide, allowing the replacement of some kidney functions by diffusion and ultrafiltration processes. Over 4 million people require some form of renal replacement therapy, with hemodialysis being the most common. During the procedure, contaminants in the water and the resulting dialysate may pass into the patient's blood and lead to toxicity. Thus, the quality of the associated dialysis solutions is a critical issue. Accordingly, the discussion of the importance of a dialysis water delivery system controlled by current standards and recommendations, with efficient monitoring methods, disinfection systems, and chemical and microbiological analysis, is crucial for improving the health outcomes of these patients...
June 28, 2023: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37661096/corporate-members
#40
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
October 2023: Therapeutic Apheresis and Dialysis
journal
journal
40470
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.